Intermolecular

Interactive explainers mapping how medicines move from first molecule to market — and where the opportunities and attrition lie along the way.

Pipeline tutorials

Walk a candidate through development, stage by stage.

Disease indications

How good is the preclinical evidence base, really — and what does the clinic cost? Indication by indication, starting with Parkinson's.

Parkinson's diseaseAnimal-model validity and the translation ledger
Coming soonOncologyImmunologyRare disease
Coming soon

Business opportunity

Weigh indications as investments — unmet need, market size, competitive density, and probability of success in one view.

Unmet needMarket sizeCompetitionProbability of success